Last reviewed · How we verify

NCT04992650

Ultrasonic Perfusion Imaging in Post-mastectomy Irradiated Patients

ENROLLING BY INVITATION NA Last updated 17 December 2025
What this trial tests

NA trial testing Fat grafting in Breast Reconstruction in 15 participants. Enrolling by invitation.

Timeline
1 March 2021
Primary endpoint
15 August 2026
15 August 2026

Quick facts

Lead sponsorMayo Clinic
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposediagnostic
Enrollment15
Start date1 March 2021
Primary completion15 August 2026
Estimated completion15 August 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Mayo Clinic

Who can join

18 and older, female only, with Breast Reconstruction or Radiation Dermatitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate post-mastectomy breast skin blood supply (perfusion) after radiation therapy, and before and after fat grafting to the breast(s).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The Effects of Radiotherapy on the Sequence and Eligibility of Breast Reconstruction: Current Evidence and Controversy.
    Campbell AR, Didier AJ, Sheikh TM, Ansari S, et al · · 2024 · cited 4× · PMID 39272797 · DOI 10.3390/cancers16172939

Verify or expand the search:

Other trials of Fat grafting

Trials testing the same drug.

Other recruiting trials for Breast Reconstruction

Currently open trials in the same condition.

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04992650.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing